Clinical Evaluation of the Efficacy of Dietary Supplement "Sulforaphane" on Hepatic Function of Subjects
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000024017
- Lead Sponsor
- Kagome CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1) Subjects who had serious liver disease or are suspected liver disease 2) Subjects with heart disease, kidney disease, diabetes and other serious disease 3) Subjects who had serious disease and judge not to be suitable for this study. 4) subjects with risk of allergy regarding to this study 5) Subjects who habitually consume higher amount of alchohol (> 60 g alcohol/day) 6) Subjects who cannot stop the use of medicinse, herbal medicinse and health foods which may affect this study 7) Subjects who cannot take test foods following the instruction and write daily diary 8) Subjects who are in other clinical trials, or participated in other clinical trials within 2 months 9) Female subjects who is breast-feeding or in pregnancy, or plan to get pregnant during this study period 10) Subjects who are judged unsuitable for this study by principal investigator and doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biomarkers of liver function(ALT, AST and gamma-GTP) before and 4, 12, 24 weeks after the intervention with "sulforaphane" or placebo
- Secondary Outcome Measures
Name Time Method Physical parameters, Hematologic values, Blood biochemical values, Urinalysis values, Fatigue questionnaire